Literature DB >> 1815591

Biosynthetic antibody binding sites: development of a single-chain Fv model based on antidinitrophenol IgA myeloma MOPC 315.

J E McCartney1, L Lederman, E A Drier, N A Cabral-Denison, G M Wu, R S Batorsky, J S Huston, H Oppermann.   

Abstract

The functional antigen binding region of antidinitrophenol mouse IgA myeloma MOPC 315 has been produced as a single-chain Fv (sFv) protein in E. coli. Recombinant 315 proteins included sFv alone, a bifunctional fusion protein with amino-terminal fragment B (FB) of staphylococcal protein A, and a two-chain 315 Fv fragment. Successful refolding of the 315 sFv required formation of disulfide bonds while the polypeptide was in a denatured state, as previously observed for the parent Fv fragment. Affinity-purified recombinant 315 proteins showed full recovery of specific activity, with values for Ka,app of 1.5 to 2.2 x 10(6) M-1, equivalent to the parent 315 Fv fragment. As observed for natural 315 Fv, the sFv region of active FB-sFv315 fusion protein was resistant to pepsin treatment, whereas inactive protein was readily degraded. These experiments will allow the application of protein engineering to the 315 single-chain Fv; such studies can advance structure-function studies of antibody combining sites and lead to an improved understanding of single-chain Fv proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1815591     DOI: 10.1007/BF01025718

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  41 in total

1.  UNFOLDING AND RENATURATION OF A UNIVALENT ANTIHAPTEN ANTIBODY FRAGMENT.

Authors:  M E NOELKEN; C TANFORD
Journal:  J Biol Chem       Date:  1964-06       Impact factor: 5.157

2.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

3.  Folding proteins.

Authors:  N J Darby; T E Creighton
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

4.  Cloning, sequencing and expression of the rearranged MOPC 315 VH gene segment.

Authors:  A Rinfret; C Horne; K J Dorrington; M Klein
Journal:  Mol Immunol       Date:  1989-04       Impact factor: 4.407

5.  Molecular characterization of antibodies bearing Id-460. I. The structure of two highly homologous VH genes used to produce idiotype positive immunoglobulins.

Authors:  E A Dzierzak; C A Janeway; N Richard; A Bothwell
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

6.  A comparison of strategies to stabilize immunoglobulin Fv-fragments.

Authors:  R Glockshuber; M Malia; I Pfitzinger; A Plückthun
Journal:  Biochemistry       Date:  1990-02-13       Impact factor: 3.162

7.  Amino-acid sequence of the variable region of the heavy (alpha) chain of a mouse myeloma protein with anti-hapten activity.

Authors:  S H Francis; R G Leslie; L Hood; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

8.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors:  J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  Sequential 1H NMR assignments and secondary structure of the B domain of staphylococcal protein A: structural changes between the free B domain in solution and the Fc-bound B domain in crystal.

Authors:  H Torigoe; I Shimada; A Saito; M Sato; Y Arata
Journal:  Biochemistry       Date:  1990-09-18       Impact factor: 3.162

10.  Mouse immunoglobulin A: nucleotide sequence of the structural gene for the alpha heavy chain derived from cloned cDNAs.

Authors:  C Auffray; R Nageotte; J L Sikorav; O Heidmann; F Rougeon
Journal:  Gene       Date:  1981-05       Impact factor: 3.688

View more
  5 in total

1.  Multisite association by recombinant proteins can enhance binding selectivity. Preferential removal of immune complexes from serum by immobilized truncated FB analogues of the B domain from staphylococcal protein A.

Authors:  J S Huston; C Cohen; D Maratea; F Fields; M S Tai; N Cabral-Denison; R Juffras; D C Rueger; R J Ridge; H Oppermann
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

Review 2.  Antigen recognition and targeted delivery by the single-chain Fv.

Authors:  J S Huston; M S Tai; J McCartney; P Keck; H Oppermann
Journal:  Cell Biophys       Date:  1993 Jan-Jun

3.  A universal antibody-derived targeting agent.

Authors:  R A Spooner; M P Deonarain; P Savage; A A Epenetos
Journal:  Cell Biophys       Date:  1993 Jan-Jun

4.  Production of a single-chain variable fragment antibody recognizing type III mutant epidermal growth factor receptor.

Authors:  N Nakayashiki; K Yoshikawa; K Nakamura; N Hanai; K Okamoto; S Okamoto; M Mizuno; T Wakabayashi; S Saga; J Yoshida; T Takahashi
Journal:  Jpn J Cancer Res       Date:  2000-10

5.  Construction, characterisation and kinetics of a single chain antibody recognising the tumour associated antigen placental alkaline phosphatase.

Authors:  P Savage; G Rowlinson-Busza; M Verhoeyen; R A Spooner; A So; J Windust; P J Davis; A A Epenetos
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.